Correction: ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells

In this article (Mol Cancer Ther 2010;9:1503–14), which was published in the June 1, 2010 issue of Molecular Cancer Therapeutics (1), the labels of Figs. 1B and C were not aligned correctly. The correct Figure 1 appears here. The online article has been changed to reflect this correction and no longer matches the print.

• Download figure
• Open in new tab
• Download powerpoint

Figure 1.

• ©2010 American Association for Cancer Research.